Join the Hot Flashes group to help and get support from people like you.
Hot Flashes News (Page 2)
Related terms: Hot Flushes
Hormone Therapy Doesn't Increase Women's Risk of Brain Tumors
TUESDAY, Jan. 21, 2025 – Hormone replacement therapy to ease menopause symptoms doesn’t increase a woman’s risk of brain tumors. Researchers found no link between hormone therapy and gliomas, the mos...
Hormone Therapy Not Associated With Glioma Risk in Women
WEDNESDAY, Jan. 15, 2025 – There seems to be no association between hormone therapy (HT) and glioma risk among U.S. women, according to a study published online Jan. 14 in Menopause. Jinyu Pan, from...
Rural Women May Have Higher Burden of Menopause Symptoms
TUESDAY, Jan. 7, 2025 – Women living in rural areas may experience a greater burden of psychological and somatic menopause symptoms, according to a study published in the January issue of Menopause. ...
Sexual Minority Women Report Better Sexual Functioning Than Heterosexual Women
FRIDAY, Dec. 20, 2024 – Sexual minority women (SMW) report better sexual functioning in midlife than their heterosexual peers, according to a study published online Dec. 17 in Menopause. Laura A....
Postmenopausal Women Have Higher Risk for Developing Rheumatoid Arthritis
WEDNESDAY, Dec. 18, 2024 -- Postmenopausal women, particularly those who experience early menopause, may have a higher risk for developing rheumatoid arthritis (RA), according to a review published ...
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
WEDNESDAY, Dec. 18, 2024 – The U.S. Food and Drug Administration (FDA) has issued its most serious warning – a black-box warning – for Veozah, a medication used to relieve hot flashes in...
Some HRT Pills May Pose Special Risk for Blood Clots
THURSDAY, Nov. 28, 2024 – Certain hormone replacement therapy pills appear to increase the risk of heart disease and serious blood clots in women going through menopause, a new study says....
Short-Term Hormone Therapy for Menopause Won't Harm Women's Brains
FRIDAY, Nov. 22, 2024 – Four years of hormone replacement therapy to help women deal with menopausal symptoms causes no harm to the brain, even over the long term, new research shows. "In the...
More Hot Flashes Could Mean Higher Odds for Type 2 Diabetes
MONDAY, Nov. 4, 2024 – Menopausal women with frequent hot flashes and night sweats are more likely to develop type 2 diabetes, a new study warns. Middle-aged women who regularly suffer those...
Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes
FRIDAY, Nov. 1, 2024 – Vasomotor symptoms (VMS) during the menopause transition (MT) are associated with an increased risk for type 2 diabetes (T2D), according to a research letter published online...
Late-Life Menopause Linked to Higher Asthma Risk
WEDNESDAY, Oct. 30, 2024 – Women who enter menopause at a later age have a greater risk of asthma, a new study says. Meanwhile, early menopause is associated with a reduced risk of developing...
Lower Risk for Asthma Seen With Younger Age at Natural Menopause
WEDNESDAY, Oct. 30, 2024 – Women with younger age at natural menopause have a reduced risk for asthma, according to a study published online Oct. 29 in Menopause. Durmalouk Kesibi, from York...
Primary Care EHRs Fail to Capture Extent of Menopause Symptoms
MONDAY, Oct. 7, 2024 – Electronic health record (EHR) documentation seen in primary care does not accurately reflect menopause symptom burden, and many women are not getting the treatment they need,...
1999 to 2020 Saw Decline in Menopausal Hormone Therapy Use
MONDAY, Sept. 30, 2024 – From 1999 to 2020, there was a decrease in menopausal hormone therapy (MHT) use among postmenopausal women, according to a study published online Sept. 27 in JAMA Health...
Hot Flashes May Occur More Often in Second Half of Nightly Sleep
MONDAY, Sept. 16, 2024 – Hot flashes (HFs) may pose a larger burden during the second half of the night, according to a study presented at the annual meeting of the Menopause Society, held from...
Further information
Related condition support groups
Related drug support groups
gabapentin, citalopram, mirtazapine, fluoxetine, venlafaxine, duloxetine, paroxetine, desvenlafaxine